Printer Friendly

ORTHOFIX INTERNATIONAL ANNOUNCES RESULTS FOR SECOND QUARTER 1992

 ORTHOFIX INTERNATIONAL ANNOUNCES RESULTS FOR SECOND QUARTER 1992
 CURACAO, Netherlands Antilles, July 24 /PRNewswire/ -- Orthofix International N.V. (NASDAQ: OFIXF), a leading supplier of external fixation devices, today announced its consolidated results for the second quarter ended June 30, 1992. Sales increased 40 percent to $6,622,000, from $4,643,000 in the second quarter of 1991. Net income for the quarter increased 51 percent, from $813,000 last year to $1,312,000, and earnings per share increased 44 percent, from $0.09 to $0.13.
 Edgar Wallner, president of Orthofix, said: "The progress we have made so far in fiscal 1992 is highly encouraging. This was an extremely exciting quarter for Orthofix, highlighted by our Riva Conference in May, the completion of the European trials for our Fracture Measuring System, and our initial public offering in the U.S."
 The Second Riva Conference on Current Perspectives in External and Intrameduallary Fixation took place at the end of May. This international meeting was organized by Orthofix and was first held in Riva del Garda, Italy in 1986. Over 800 delegates including over 500 surgeons from 33 countries attended this year's meeting. Nearly 200 scientific papers were presented, of which 83 related to the use of Orthofix's products in surgical procedures.
 The company also completed the European trials of its Fracture Measuring System, which will assist surgeons in objectively assessing the healing point of a fracture with equipment which can be sited in the doctor's office and without using X-rays. Orthofix intends to market this system outside the USA commencing in the last quarter of 1992, and will apply to the Food and Drug Administration for a Pre-Marketing Approval (PMA) in the third quarter.
 In 1980 Italy was the first country in which Orthofix was launched and the Italian distributor, D.M.O., of which Orthofix acquired 60 percent in January 1992, increased its Orthofix sales by 29 percent in the first six months of the year. D.M.O. also obtained the Italian distribution rights for the intavent Laryngeal Mask, a unique device used in anesthesia for which Health Ministry approval was granted in May.
 Orthofix International N.V. is a leading producer of external fixation devices, limb lengthening and bone reconstruction equipment. External fixation is generally less invasive, more cost effective and offers better clinical results than alternative methods. The company sells its products through independent distributors in 44 countries, and through D.M.O. Sri in Italy. The company's sales have increased from $7.9 million in 1988 to $20.9 million in 1991. The United States represents Orthofix's largest market. Orthofix completed its U.S. initial public offering in April 1992.
 -0- 7/24/92
 /CONTACT: Edgar Wallner or Peter Clarke of Orthofix, in England: 011-44-91-579-600, or (fax) 011-44-91-579-750, or Debra Wasser or Joe Mileti of Dewe Rogerson Inc., 212-688-6840, or 212-838-3393, for Orthofix/
 /FIRST AND FINAL ADD -- TABULAR MATERIAL -- TO FOLLOW/
 (OFIXF) CO: Orthofix International N.V. ST: IN: SU: ERN


TS-OS -- NY009 -- 2936 07/24/92 09:41 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 24, 1992
Words:506
Previous Article:INTERFIRST BANKCORP, INC. REPORTS EARNINGS
Next Article:FRUEHAUF STARTS JOINT VENTURE FOR AXLES IN CHINA
Topics:


Related Articles
ORTHOFIX REPORTS RECORD YEAR-END RESULTS
ORTHOFIX ANNOUNCES FIRST QUARTER RESULTS
ORTHOFIX INTERNATIONAL N.V. ANNOUNCES THIRD QUARTER RESULTS
ORTHOFIX REPORTS YEAR-END RESULTS; 1994 NET INCOME UP BY 18%; 26% INCREASE IN REVENUES
ORTHOFIX REPORTS FIRST QUARTER RESULTS; REVENUES UP 23%; 38% INCREASE IN NET INCOME
AMERICAN MEDICAL ELECTRONICS ANNOUNCES SECOND QUARTER RESULTS, CONTINUED PROGRESS OF ORTHOFIX PRODUCT DISTRIBUTION AND MERGER
ORTHOFIX REPORTS THIRD QUARTER RESULTS
ORTHOFIX PREVIEWS THIRD QUARTER
ORTHOFIX REPORTS PRELIMINARY YEAR END AND FOURTH QUARTER SALES AND INDICATES FOURTH QUARTER LOSS
ORTHOFIX REPORTS YEAR END RESULTS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters